Digital therapy for copd self-management
Part of Lungs & breathing clinical trials.
This trial tests a smartphone-based program to help people with COPD manage their condition at home. It may help you track symptoms and avoid flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD.
- You are 40 years old or older.
- You had at least one severe flare-up in the last year, but have been stable for the past 4 weeks.
- You can use a smartphone comfortably.
- You use inhaler medication that works with the study's monitoring device.
- You understand the study and agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a home monitoring program for people with COPD (a long-term lung condition) to track symptoms using a phone or tablet. It may help clinicians spot changes earlier and improve how COPD care is managed.
This trial tests an online program called EmoEase that helps COPD patients manage their emotions through smartphone exercises. You would use a WeChat applet for 8 weeks, with short daily sessions, and attend three check-ups over four months.
This trial tests a smart home breathing guidance system for people with stable COPD. It aims to help improve your ability to exercise and be active using a remote coaching program you can follow at home.
This study tests a smartphone app designed to help you track and manage your COPD symptoms day-to-day. It includes a small device you use at home to measure your lung function, aiming to help you catch problems early and stay healthier.
This trial tests a smartphone-based program to help people with COPD manage their condition and feel better. You will use WhatsApp or WeChat to get support and track your activity.
This study tests a digital version of the 'Living Well with COPD' program to help you learn about managing your condition at home. You can join if you have COPD, speak German or French, and have internet access.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.